Cargando…

Association between Oral Chinese Herbal Medicine and Recurrence and Metastasis in Patients with Stages II and III Colorectal Cancer: A Cohort Study in China

BACKGROUND: To evaluate the associations between long-term oral Chinese herbal medicines (CHMs) and recurrence and metastasis (R&M) in patients with stage II and III colorectal cancer (CRC). Furthermore, we aimed to determine the correlation between different syndrome patterns and prognosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Mo, Zhang, Wei, Qin, Wenyu, Zou, Chao, Yan, Yunzi, He, Bin, Xu, Yun, Zhang, Ying, Liu, Jianping, Sun, Hong, Yang, Yufei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666030/ https://www.ncbi.nlm.nih.gov/pubmed/36397996 http://dx.doi.org/10.1155/2022/8529395

Ejemplares similares

Machine learning based prognostic model of Chinese medicine affecting the recurrence and metastasis of I-III stage colorectal cancer: A retrospective study in China
por: Tang, Mo, et al.
Publicado: (2022)

Role of Traditional Chinese Medicine Syndrome Type, Gut Microbiome, and Host Immunity in Predicting Early and Advanced Stage Colorectal Cancer
por: Yan, Yunzi, et al.
Publicado: (2023)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
por: Xu, Guozeng, et al.
Publicado: (2021)

Implications of Habitual Alcohol Intake With the Prognostic Significance of Mean Corpuscular Volume in Stage II-III Colorectal Cancer
por: Liu, Qi, et al.
Publicado: (2021)

Oral Chinese herbal medicine in reducing the recurrence of colorectal adenoma after polypectomy: A protocol for the systematic review and meta-analysis
por: Cheng, Yi, et al.
Publicado: (2023)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery
por: Huang, Mingliang, et al.
Publicado: (2022)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Occult neoplastic cells in lymph node sinuses and recurrence/metastasis of stage II/III gastric cancer
por: SEKIDO, YASUTOMO, et al.
Publicado: (2014)

Does physical activity associate with gut microbiome and survival outcomes of Chinese metastatic colorectal cancer patients? A secondary analysis of a randomized controlled trial
por: Sun, Lingyun, et al.
Publicado: (2022)

Hypomethylation-Associated Up-Regulation of TCF3 Expression and Recurrence in Stage II and III Colorectal Cancer
por: Li, Chunxiang, et al.
Publicado: (2014)

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing
por: Kishigami, Fumishi, et al.
Publicado: (2022)

Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences
por: D'Oronzo, Stella, et al.
Publicado: (2021)

Two tripartite classification systems of CD86(+) and CD206(+) macrophages are significantly associated with tumor recurrence in stage II-III colorectal cancer
por: Xu, Guozeng, et al.
Publicado: (2023)

Patient Reported Traditional Chinese Medicine Spleen Deficiency Syndrome (TCM-SDS) Scale for Colorectal Cancer: Development and Validation in China
por: Sun, Lingyun, et al.
Publicado: (2021)

Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III
por: Kim, Ho Seung, et al.
Publicado: (2013)

The Prognosis and Recurrence Pattern of Right- and Left-Sided Colon Cancer in Stage II, Stage III, and Liver Metastasis After Curative Resection
por: Nakamura, Yasuyuki, et al.
Publicado: (2021)

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
por: Alliot, C
Publicado: (2004)

Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer
por: Park, Jung Won, et al.
Publicado: (2022)

Does Chinese herbal medicine (CHM) reduce colorectal adenoma (CRA) recurrence: protocol of a registry-based, cohort study and a qualitative interview
por: Cheng, Yi, et al.
Publicado: (2023)

Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer
por: Cavalleri, Tommaso, et al.
Publicado: (2022)

Identification of a ferroptosis-related gene signature predicting recurrence in stage II/III colorectal cancer based on machine learning algorithms
por: Wang, Ze, et al.
Publicado: (2023)

Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
por: Yuan, Zhen, et al.
Publicado: (2022)

Reply: Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
por: Ohwada, S, et al.
Publicado: (2004)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Risk factors for postoperative recurrence in patients with stage II colorectal cancer
por: Xiong, Zhi-Zhong, et al.
Publicado: (2023)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Identification and characterization of ANO9 in stage II and III colorectal carcinoma
por: Li, Chunxiang, et al.
Publicado: (2015)

Microsatellite instability & survival in patients with stage II/III colorectal carcinoma
por: Srdjan, Markovic, et al.
Publicado: (2016)

Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer
por: Cai, Du, et al.
Publicado: (2023)

Development and validation of a collagen signature to predict the prognosis of patients with stage II/III colorectal cancer
por: Dong, Shumin, et al.
Publicado: (2023)

Predictors of recurrence free survival for patients with stage II and III colon cancer
por: Tsikitis, Vassiliki L, et al.
Publicado: (2014)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
por: Kim, Jung Ho, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q6qg7b0a1log4vv7f1gsk126iu